Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.

Autor: Coussy, F.1,2,3 (AUTHOR) florence.coussy@curie.fr, El Botty, R.2 (AUTHOR), Lavigne, M.4 (AUTHOR), Gu, C.4 (AUTHOR), Fuhrmann, L.4 (AUTHOR), Briaux, A.1 (AUTHOR), de Koning, L.5 (AUTHOR), Dahmani, A.2 (AUTHOR), Montaudon, E.2 (AUTHOR), Morisset, L.2 (AUTHOR), Huguet, L.2 (AUTHOR), Sourd, L.2 (AUTHOR), Painsec, P.2 (AUTHOR), Chateau-Joubert, S.6 (AUTHOR), Larcher, T.7 (AUTHOR), Vacher, S.1 (AUTHOR), Melaabi, S.1 (AUTHOR), Salomon, A. Vincent4 (AUTHOR), Marangoni, E.2 (AUTHOR), Bieche, I.1,8 (AUTHOR)
Zdroj: Journal of Hematology & Oncology. 2/22/2020, Vol. 13 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje